Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid
ClinicalTrials.gov study NCT00418665. IPD Sharing: Not stated. Countries: 0. Publications: 1.
5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)
ClinicalTrials.gov study NCT00897130. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00732316. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES
ClinicalTrials.gov study NCT01291745. IPD Sharing: Not stated. Countries: 1. Publications: 27.
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02975869. IPD Sharing: NO. Countries: 1. Publications: 2.
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
ClinicalTrials.gov study NCT04655755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory Disorders
ClinicalTrials.gov study NCT02985190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00600860. IPD Sharing: NO. Countries: 18. Publications: 7.
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
ClinicalTrials.gov study NCT03128034. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01130506. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04022785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00911066. IPD Sharing: Not stated. Countries: 1. Publications: 2.
SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00495547. IPD Sharing: Not stated. Countries: 1. Publications: 32.
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00003593. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00803530. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes
ClinicalTrials.gov study NCT03363399. IPD Sharing: YES. Countries: 1. Publications: 2.
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00002798. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02749708. IPD Sharing: NO. Countries: 1. Publications: 1.
Ruxolitinib for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01895842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma
ClinicalTrials.gov study NCT04582539. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.